Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 9651 - 9675 of 10443 in total
Experimental
AGI-1067, is a novel small molecule with anti-oxidant and anti-inflammatory properties that was discovered by AtheroGenics and designed to treat atherosclerosis of the blood vessels of the heart, or coronary artery disease.
Investigational
Experimental
Latrunculin B is a 14-membered macrolide attached to 2-thiazolidinone moiety, isolated from Red Sea sponge Latrunculia magnifica.
Experimental
Netoglitazone (MCC-555) is a hypoglycemic agent.
Experimental
Matched Categories: … Blood Glucose Lowering Agents
Vet approved
E7820 has been investigated for the treatment of Colon Cancer and Rectal Cancer.
Investigational
Nelotanserin has been used in trials studying the treatment of Lewy Body Dementia, Visual Hallucinations, Dementia With Lewy Bodies, and REM Sleep Behavior Disorder. It is a highly selective antagonist at the 5-HT2A serotonin receptor. It increases non-REM sleep, the most restorative phase of the sleep cycle, without sacrificing REM...
Investigational
Tonapofylline has been used in trials studying the treatment of Heart Failure, Renal Insufficiency, and Congestive Heart Failure.
Investigational
Mavoglurant has been used in trials studying the treatment of Patient Diagnosed With OCD and and Resistant to SSRI Treatment (Failed SSRI Over 12 Weeks at Appropriate Doses).
Investigational
Experimental
Investigational
Experimental
Experimental
Experimental
Displaying drugs 9651 - 9675 of 10443 in total